Phil Dunne writes to The Economist from London:
Let us create a relationship between athletes and companies, as in Formula One motor racing, that combines the greatest talents with the best innovators… A Dwain Chambers/Glaxo-SmithKline team would compete against a Tim Montgomery/Pfizer team. The benefits would be large: drug safety would be enhanced […] it would create a spectacle the spectacle of “super-humans” capable of running 100 metres in four or five seconds…
Why not? Most athletes are ruining themselves with drugs and overwork anyway.
Actually, shivers are all over my spine: how soon are we going to see creatures from a monster movie on stadium tracks? For it will come to gene-doping eventually.